Logo image of BKN

BLACKROCK INVEST QLTY MUNI (BKN) Stock Price, Quote, News and Overview

NYSE:BKN - New York Stock Exchange, Inc. - US09247D1054 - Currency: USD

10.73  -0.14 (-1.29%)

Fundamental Rating

1

Taking everything into account, BKN scores 1 out of 10 in our fundamental rating. BKN was compared to 0 industry peers in the Unkown industry. BKN may be in some trouble as it scores bad on both profitability and health. BKN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BKN had negative earnings in the past year.
The reported net income has been mixed in the past 5 years: BKN reported negative net income in multiple years.
BKN had a positive operating cash flow in each of the past 5 years.
BKN Yearly Net Income VS EBIT VS OCF VS FCFBKN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

1.2 Ratios

Industry RankSector Rank
ROA -0.49%
ROE -0.56%
ROIC 2.18%
ROA(3y)0.15%
ROA(5y)0.86%
ROE(3y)0.14%
ROE(5y)0.95%
ROIC(3y)2.25%
ROIC(5y)2.22%
BKN Yearly ROA, ROE, ROICBKN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10

1.3 Margins

In the last couple of years the Operating Margin of BKN has declined.
BKN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 53.77%
PM (TTM) N/A
GM 58.64%
OM growth 3Y-6.38%
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.06%
GM growth 5Y-4.53%
BKN Yearly Profit, Operating, Gross MarginsBKN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200 -200

More info and screens

2

2. Health

2.1 Basic Checks

BKN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BKN has more shares outstanding
The debt/assets ratio for BKN has been reduced compared to a year ago.
BKN Yearly Shares OutstandingBKN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
BKN Yearly Total Debt VS Total AssetsBKN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 2.72 indicates that BKN is not a great score, but indicates only limited risk for bankruptcy at the moment.
BKN has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 2.72
ROIC/WACCN/A
WACCN/A
BKN Yearly LT Debt VS Equity VS FCFBKN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.3 Liquidity

BKN has a Current Ratio of 1.07. This is a normal value and indicates that BKN is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.07 indicates that BKN should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 1.07
BKN Yearly Current Assets VS Current LiabilitesBKN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

BKN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 95.71%, which is quite impressive.
The Revenue has decreased by -0.65% in the past year.
Measured over the past years, BKN shows a decrease in Revenue. The Revenue has been decreasing by -1.58% on average per year.
EPS 1Y (TTM)95.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%307.63%
Revenue 1Y (TTM)-0.65%
Revenue growth 3Y-3.33%
Revenue growth 5Y-1.58%
Sales Q2Q%-10.05%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BKN Yearly Revenue VS EstimatesBKN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BKN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BKN Price Earnings VS Forward Price EarningsBKN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BKN Per share dataBKN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.77%, BKN is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.46, BKN pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.77%

5.2 History

The dividend of BKN decreases each year by -6.54%.
BKN has been paying a dividend for at least 10 years, so it has a reliable track record.
BKN has decreased its dividend recently.
Dividend Growth(5Y)-6.54%
Div Incr Years1
Div Non Decr Years1
BKN Yearly Dividends per shareBKN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of BKN are negative and hence is the payout ratio. BKN will probably not be able to sustain this dividend level.
DP-304.24%
EPS Next 2YN/A
EPS Next 3YN/A
BKN Yearly Income VS Free CF VS DividendBKN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

More info and screens

BLACKROCK INVEST QLTY MUNI

NYSE:BKN (4/28/2025, 11:56:51 AM)

10.73

-0.14 (-1.29%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners29.8%
Inst Owner Change3.98%
Ins Owners0%
Ins Owner Change0.13%
Market Cap184.66M
Analysts0
Price TargetN/A
Short Float %0.1%
Short Ratio0.31
Dividend
Industry RankSector Rank
Dividend Yield 5.77%
Yearly Dividend0.64
Dividend Growth(5Y)-6.54%
DP-304.24%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-15 2025-04-15 (0.057)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.96
P/FCF N/A
P/OCF N/A
P/B 0.63
P/tB 0.63
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.98
BVpS17.08
TBVpS17.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.49%
ROE -0.56%
ROCE 2.76%
ROIC 2.18%
ROICexc 2.18%
ROICexgc 2.18%
OM 53.77%
PM (TTM) N/A
GM 58.64%
FCFM N/A
ROA(3y)0.15%
ROA(5y)0.86%
ROE(3y)0.14%
ROE(5y)0.95%
ROIC(3y)2.25%
ROIC(5y)2.22%
ROICexc(3y)2.25%
ROICexc(5y)2.22%
ROICexgc(3y)2.25%
ROICexgc(5y)2.22%
ROCE(3y)2.85%
ROCE(5y)2.81%
ROICexcg growth 3Y-3.66%
ROICexcg growth 5Y-3.02%
ROICexc growth 3Y-3.66%
ROICexc growth 5Y-3.02%
OM growth 3Y-6.38%
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.06%
GM growth 5Y-4.53%
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.07
Quick Ratio 1.07
Altman-Z 2.72
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)95.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%307.63%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.65%
Revenue growth 3Y-3.33%
Revenue growth 5Y-1.58%
Sales Q2Q%-10.05%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.77%
EBIT growth 3Y-9.49%
EBIT growth 5Y-6.29%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y154.35%
FCF growth 3Y91.47%
FCF growth 5Y55.48%
OCF growth 1Y154.35%
OCF growth 3Y91.47%
OCF growth 5Y55.48%